These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma. Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309 [TBL] [Abstract][Full Text] [Related]
4. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone. Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma. Sasaki K; Uchikado Y; Omoto I; Arigami T; Osako Y; Noda M; Okumura H; Maemura K; Higashi R; Yoshiura T; Natsugoe S Cancer Chemother Pharmacol; 2019 Mar; 83(3):581-587. PubMed ID: 30623230 [TBL] [Abstract][Full Text] [Related]
6. Immunoblotting in Detection of Tumor-Associated Antigens in Esophageal Squamous Cell Carcinoma. Islam F; Gopalan V; Lam AK Methods Mol Biol; 2020; 2129():269-277. PubMed ID: 32056184 [TBL] [Abstract][Full Text] [Related]
7. Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma. Leng XF; Daiko H; Han YT; Mao YS Ann N Y Acad Sci; 2020 Dec; 1482(1):213-224. PubMed ID: 33067818 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903). Sun HB; Xing WQ; Liu XB; Zheng Y; Yang SJ; Wang ZF; Liu SL; Ba YF; Zhang RX; Liu BX; Fan CC; Chen PN; Liang GH; Yu YK; Liu Q; Wang HR; Li HM; Li ZX; BMC Cancer; 2020 Apr; 20(1):303. PubMed ID: 32293362 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC Experience. Nobel TB; Barbetta A; Hsu M; Tan KS; Pinchinat T; Schlottmann F; Bains MS; Ku GY; Wu AJ; Patti MG; Jones DR; Molena D J Gastrointest Surg; 2019 Jan; 23(1):11-22. PubMed ID: 30215197 [TBL] [Abstract][Full Text] [Related]
10. Application of Pathological Staging in Esophageal Squamous Cell Carcinoma. Lam AK Methods Mol Biol; 2020; 2129():19-31. PubMed ID: 32056167 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry for Protein Detection in Esophageal Squamous Cell Carcinoma. Kasem K; Lam AK Methods Mol Biol; 2020; 2129():279-294. PubMed ID: 32056185 [TBL] [Abstract][Full Text] [Related]
12. Minimal residual disease guided radical chemoradiotherapy combined with immunotherapy after neoadjuvant immunochemotherapy followed by adjuvant immunotherapy for esophageal squamous cell cancer (ECMRD-001): a study protocol for a prospective cohort study. Wang H; Zhang X; Zhao X; Song C; Deng W; Shen W Front Immunol; 2023; 14():1330928. PubMed ID: 38274807 [TBL] [Abstract][Full Text] [Related]
13. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy]. Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques. Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166 [TBL] [Abstract][Full Text] [Related]
15. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma. Chen J; Yin W; Yao H; Gu W Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757 [TBL] [Abstract][Full Text] [Related]
16. Surgical Protocols for Squamous Cell Cancer of the Esophagus. Moreno MCF; Law S Methods Mol Biol; 2020; 2129():335-358. PubMed ID: 32056189 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010. Chen D; Kong M; Sun J; Yang H; Chen Y; Fang W; Yu Z; Mao W; Xiang J; Han Y; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Yang H; Li T; Zhang X; Li Q; Wang G; Mao T; Guo X; Lin T; Liu M; Witharana P; Fu J; Chen B; Shen J; Zhu C J Thorac Cardiovasc Surg; 2023 Mar; 165(3):888-897. PubMed ID: 36137841 [TBL] [Abstract][Full Text] [Related]
18. Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease? Huang PM; Hsu FM; Lin CC; Hsu CH; Cheng JC; Lee JM Dig Surg; 2018; 35(2):104-110. PubMed ID: 28675905 [TBL] [Abstract][Full Text] [Related]
19. Investigation of operative outcomes of thoracoscopic esophagectomy after triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal squamous cell carcinoma. Akiyama Y; Iwaya T; Endo F; Chiba T; Takahara T; Otsuka K; Nitta H; Koeda K; Mizuno M; Kimura Y; Sasaki A Surg Endosc; 2018 Jan; 32(1):391-399. PubMed ID: 28664431 [TBL] [Abstract][Full Text] [Related]
20. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma. Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]